Paris based pharmaceutical company Sanofi-Aventis SA, currently valued at about 29.3 Billion Euros, is currently looking to boost its presence in the rapidly expanding market for diabetes solutions in India, including diagnostic systems that would check blood sugar levels.

Recently, Sanofi joined hands with AgaMatrix Inc. to develop monitors to measure blood glucose.

"We don’t want to be a single-product company; we are moving from treatment to diabetes solution. When you think about a diabetic patient using insulin, it’s not only injecting insulin; it’s monitoring his blood glucose (level), minimum once a day", said Pierre Chancel, Global Head of Sanofi's newly created diabetes unit.

Sanofi is planning to launch its blood sugar monitors in India over the coming year.

According to Mr. Chancel, Sanofi is looking to offer a complete diabetes solution.